The study of variant s antigen expression revealing a novel c.160C>T (p.Arg54Cys) variant on GYPB*s allele associated with partial s phenotype.

BACKGROUND: Little s antigen is mainly defined by a single nucleotide polymorphism at c.143C (p.Thr48) on the GYPB gene. Several variants on GYPB can alter the expression of s antigen. The aim of this study was to investigate the molecular basis of variant s antigen expression in the Chinese population. STUDY DESIGN AND METHODS: A total of 4983 whole blood samples were collected to screen the individuals with discrepant s typing results using two different monoclonal anti-s. Then, the sequence of GYPB exon 4 was analyzed by Sanger sequencing. Flow cytometry analysis was performed to quantify s antigen expression on red blood cells (RBCs). In vitro expression study was performed to verify the effect of the GYPB variants identified on the expression of s antigen. RESULTS: Four donors were identified to have discrepant s typing results. Sanger sequencing showed that three donors carried the c.173C > G variant (p.Pro58Arg) specific for sD antigen, the other one carried a novel GYPB (c.160C > T, p.Arg54Cys) variant. Flow cytometry identified a partial and weak expression of s antigen on the RBCs of the four donors. Furthermore, in vitro expression study confirmed the effect of the two variants on the s antigen expression. CONCLUSION: The results demonstrated that in addition to p.Thr48, the two extra amino acids p.Arg54 and p.Pro58 are also important for full expression of s antigen. Since the individuals with partial s antigen are at risk for the development of alloanti-s, it is important to select at least two different monoclonal anti-s for correct s typing.

A novel red phosphor Cs2NaGaF6:Mn4+ with ultra-strong zero-phonon lines and long wavelength phonon sidebands for high-quality WLEDs.

For high-efficiency lighting and wide color gamut backlight display, high-quality narrow-band red phosphors for WLEDs are still in high demand. Herein, a novel red-emitting fluoride phosphor Cs2NaGaF6:Mn4+ was successfully synthesized by a simple two-step co-precipitation method and exhibits ultra-intense zero-phonon lines (ZPLs) and long wavelength phonon sidebands under 468 nm blue light irradiation. The ZPL emission peak of Cs2NaGaF6:Mn4+ was located at 627 nm, which is much stronger than its υ6 vibration peak, more matchable with the eye-sensitive region of humans, and beneficial for obtaining higher luminous efficiency of WLEDs. Interestingly, the υ6 vibration peak of this red phosphor is at 636.5 nm, which is larger than that of the common fluoride phosphor A2BF6:Mn4+ (usually at about 630 nm, represented by K2SiF6:Mn4+) at about 6.5 nm. Thanks to the longer wavelength of the υ6 vibration peak, the chromaticity coordinates (0.7026, 0.2910) with a larger x-coordinate value were realized, leading to a potentially wider color gamut of WLEDs. In addition, this phosphor has high thermal stability and its emission intensity at 423 K remains 93.7% of the initial intensity at room temperature. The lumen efficiency of WLED1 packaged with a mixture of Cs2NaGaF6:Mn4+ and YAG:Ce3+ on the InGaN blue chip is 115.7 lm W-1 with the color temperature (Tc) = 3390 K and the colour rendering index (Ra) = 92.5 under 20 mA driving current. The chromaticity coordinates of WLED2 packaged with Cs2NaGaF6:Mn4+ and ß-SiAlON:Eu2+ on the InGaN blue chip are (0.3149, 0.3262) and the calculated color gamut is up to 118.4% (NTSC). These results indicate that Cs2NaGaF6:Mn4+ red phosphors have promising applications in the high-quality lighting and display fields.

Novel broadband NIR phosphors Y2Mg2Ga2Si2O12:xCr3+ for NIR LED applications.

The Cr3+-doped near-infrared (NIR) phosphors have been extensively investigated owing to their promising applications in biomedicine, food safety detection, and night vision surveillance. However, achieving broadband (FWHM > 160 nm) NIR emission is still challenging. In this paper, novel Y2Mg2Ga2-xSi2O12:xCr3+ (YMGS:xCr3+, x = 0.005-0.08) phosphors were prepared by a high-temperature solid-state reaction. The crystal structure, photoluminescence properties of the phosphor, and the device performance of a pc-LED were researched in detail. When excited at 440 nm, the YMGS:0.04Cr3+ phosphor exhibited broadband emission in the range of 650-1000 nm, peaking at 790 nm with a full width at half-maximum (FWHM) of up to 180 nm. The wide FWHM of YMGS:Cr3+ is conducive to its extensive application in NIR spectroscopic technology. In addition, the YMGS:0.04Cr3+ phosphor could maintain 70% of the initial emission intensity at 373 K. By combining the commercial blue chip with the YMGS:0.04Cr3+ phosphor, the resulting NIR pc-LED demonstrated a near-infrared output power of 14 mW with a photoelectric conversion efficiency of 5% at a drive current of 100 mA. This work provides a broadband emission NIR phosphor option for NIR pc-LED devices.

Patients with Asian-type DEL can safely be transfused with RhD-positive blood.

Red blood cells (RBCs) of Asian-type DEL phenotype express few RhD proteins and are typed as serologic RhD-negative (D-) phenotype in routine testing. RhD-positive (D+) RBC transfusion for patients with Asian-type DEL has been proposed but has not been generally adopted because of a lack of direct evidence regarding its safety and the underlying mechanism. We performed a single-arm multicenter clinical trial to document the outcome of D+ RBC transfusion in patients with Asian-type DEL; none of the recipients (0/42; 95% confidence interval, 0-8.40) developed alloanti-D after a median follow-up of 226 days. We conducted a large retrospective study to detect alloanti-D immunization in 4045 serologic D- pregnant women throughout China; alloanti-D was found only in individuals with true D- (2.63%, 79/3009), but not in those with Asian-type DEL (0/1032). We further retrospectively examined 127 serologic D- pregnant women who had developed alloanti-D and found none with Asian-type DEL (0/127). Finally, we analyzed RHD transcripts from Asian-type DEL erythroblasts and examined antigen epitopes expressed by various RHD transcripts in vitro, finding a low abundance of full-length RHD transcripts (0.18% of the total) expressing RhD antigens carrying the entire repertoire of epitopes, which could explain the immune tolerance against D+ RBCs. Our results provide multiple lines of evidence that individuals with Asian-type DEL cannot produce alloanti-D when exposed to D+ RBCs after transfusion or pregnancy. Therefore, we recommend considering D+ RBC transfusion and discontinuing anti-D prophylaxis in patients with Asian-type DEL, including pregnant women. This clinical trial is registered at www.clinicaltrials.gov as #NCT03727230.

An Initial Covalent Organic Polymer with Closed-F Edges Directly for Proton-Exchange-Membrane Fuel Cells.

Covalent organic polymers (COPs) are a class of rising electrocatalysts for the oxygen reduction reaction (ORR) due to the atomically metrical control of the organic molecular components along with highly architectural robustness and thermodynamic stability even in acid or alkaline media. However, the direct application of pristine COPs as acidic ORR electrocatalysts, especially in device manner, e.g., in proton-exchange-membrane fuel cells (PEMFCs), remains a big challenge. Currently, the decoration toward electronic structures of active sites is considered a vital pathway to enhancing the acidic ORR activity of carbon-based electrocatalysts. Here, an initial F-decorated fully closed π-conjugated quasi-phthalocyanine COP (denoted as COPBTC -F) is reported. The introduction of the closed-F edges stepwise drags more electrons from FeN4 sites in COPBTC -F into the catalyst margin, which weakens the occupied numbers of bonding orbitals between COPBTC -F and OH* intermediates at the rate-determining step, exhibiting over five times intrinsic performance beyond the counterpart without F functionalities (termed as COPBTC ). Significantly, the maximum power density utilizing COPBTC -F as a cathode catalyst in PEMFCs is remarkably increased by an order of magnitude compared with COPBTC , which is a stride forward among catalysts based on a pyrolysis-free conjugated-polymer network in device manner to date.

A novel Cr3+-doped Lu2CaMg2Si3O12 garnet phosphor with broadband emission for near-infrared applications.

Near-infrared (NIR) phosphor-converted light emitting diode (pc-LED) light sources have broad application prospects in environmental science, biomedical and plant growth fields. However, NIR phosphors still suffer from narrowband emission and low thermal stability. Here, we prepared a novel Lu2CaMg2-xSi3O12:xCr3+ (LCMS:xCr3+, x = 0.005-0.06) phosphor with broadband emission by a high-temperature solid state reaction. Under excitation at 450 nm, the emission spectrum of the LCMS:0.05Cr3+ phosphor shows a broadband emission in the range of 650-1000 nm with a large full width at half maximum (FWHM) of 125 nm and an R-line emission of 692 nm. In addition, the LCMS:0.05Cr3+ phosphor has good thermal stability and can maintain 70% emission intensity at 150 °C relative to that at room temperature. The LCMS:0.05Cr3+ phosphor exhibits a high internal quantum efficiency (IQE) of ∼76%. Using this phosphor, a NIR pc-LED with photoelectric efficiencies of 14.8% at 100 mA and 6.0% at 320 mA and NIR output powers of 59.5 mW at 100 mA and 181.0 mW at 320 mA was obtained. The broadband LCMS:0.05Cr3+ phosphor with a NIR emission peaked at 750 nm can serve as a light source for plant cultivation and has superior application prospects in the agriculture field.

Spherical Li4Ti5O12/NiO Composite With Enhanced Capacity and Rate Performance as Anode Material for Lithium-Ion Batteries.

Compositing with metal oxides is proved to be an efficient strategy to improve electrochemical performance of anode material Li4Ti5O12 for lithium-ion batteries. Herein, spherical Li4Ti5O12/NiO composite powders have been successfully prepared via a spray drying method. X-ray diffraction and high-resolution transmission electron microscopy results demonstrate that crystal structure of the powders is spinel. Scanning electron microscopy results show that NiO uniformly distributes throughout Li4Ti5O12 matrix. It is found that compositing with NiO increases both discharge platform capacity and rate stability of Li4Ti5O12. The as-prepared Li4Ti5O12/NiO (5%) exhibits a high initial discharge capacity of 381.3 mAh g-1 at 0.1 C, and a discharge capacity of 194.7 mAh g-1 at an ultrahigh rate of 20 C.

[Correlation between special A/O genotype and the O phenotype].

OBJECTIVE: To explore the correlation between special A/O genotype and the O phenotype. METHODS: Group O samples with partially reduced or lack of isoagglutinins were collected to determinate the ABO genotype with a PCR-sequence specific primer (PCR-SSP) assay. Seven samples with A/O genotype were selected for further study. Serological tests including forward and reverse typing, H antigen determination and adsorption/elution were carried out with a tube method. Genomic DNA was genotyped by amplifying and sequencing of the coding regions of exons 1 to 7 of the ABO gene. RESULTS: Seven samples were serotyped as group O by the forward typing test. However, reduced anti-A activity was found in 5 samples by the reverse typing test, reduced anti-A and anti-B activities were found in 1 sample, and no anti-A isoagglutinin activity was found with 1 sample. H antigen was determined in all samples by routine serologic method. Neither anti-A nor anti-B was eluted from red cells derived from all samples. Three samples were genotyped as Ael02/O02, whilst the remainders were Ael02/O13, Ael02/O65, Am04/O75, Ael06/O02, respectively. CONCLUSION: Special A/O genotype may not express the A antigen, leading to the generation of group O red cells. Reduced or missed anti-A activity is the typical serological feature of this special group of O phenotype, for which ABO*Ael02 and ABO*O02 are the major alleles. Group O individuals with isoagglutinin detection problem should be grouped by serological tests and genomic DNA analysis.

A Novel Semirigid Ureterorenoscope with Vacuum Suctioning System for Management of Single Proximal Ureteral and Renal Pelvic Stones: An Initial Experience.

INTRODUCTION: A novel semirigid ureterorenoscope, named the Sotn ureterorenoscope, was designed with a vacuum suction system. The present study aimed to evaluate the feasibility and safety of using the Sotn ureterorenoscope to manage single proximal ureteral or renal pelvic stones. PATIENTS AND METHODS: Data were retrospectively collected from consecutive patients treated with a Sotn ureterorenoscope between February 2010 and August 2015 at Sun Yat-sen Memorial Hospital of Sun Yat-sen University and Jiangmen Wuyi Traditional Chinese Medicine Hospital in China. The primary outcome was the primary stone-free rate (SFR) in 1 month. The secondary outcomes were the final SFR and the perioperative complication rate. RESULTS: A total of 386 patients were evaluated, including 240 males and 146 females. The median (interquartile range [IR]) age was 50 (40-59) years. There were 96 and 290 stones located in the renal pelvis and proximal ureter, respectively. The median (IR) operative time and console time for all patients were 40 (30-70) and 20 (12-38) minutes, respectively. The primary overall SFR was 86.5%, whereas the SFRs for stones with a diameter of ≤1, 1 to 2, and 2 to 3 cm were 95.7%, 86.9%, and 69.0%, respectively. Complications occurred in 90 patients (23.3%); these complications were classified as Clavien-Dindo grades 1 to 2 (minor) in 79 (20.5%) patients, and grades 3 to 4 (major) in 11 (2.8%). CONCLUSIONS: The novel semirigid Sotn ureterorenoscope featuring a vacuum suction system is effective and safe for managing proximal ureteral and renal pelvic stones.

Ultrastable and Efficient Visible-Light-Driven Hydrogen Production Based on Donor-Acceptor Copolymerized Covalent Organic Polymer.

Developing stable and efficient photocatalysts for H2 production under visible light is still a big challenge. In this work, a novel covalent organic polymer (COP)-based photocatalyst with trace ending groups was prepared by the efficient irreversible kinetic coupling reaction, i.e., nickel(0)-catalyzed Yamamoto-type Ullmann cross-coupling, using pyrene as electron donor and countpart, e.g., phenanthrolene, benzene, pyrazine, as electron acceptor. The newly developed optimal photocatalyst (termed as COP-TP3:1) has a 14-fold improvement in the H2 evolution rate from 3 to 42 µmol h-1 under visible light compared with the sample without donor-acceptor structure. Moreover, COP-TP3:1 also performs excellent photocatalytic activity under different water quality (deionized water, municipal water, commercial mineral water, and simulated seawater (NaCl 3 wt %)). Significantly, ignored decrease in H2 evolution can be observed after 20 hours cycling H2 production, and the performance is only reduced by about 7% even after discontinuous cycles of photocatalysis and storage for a month. The donor-acceptor units with trace ending groups contribute to suppress electron-holes recombination kinetics and the N coordination sites in electron-acceptors conduce to anchor Pt (as the cocatalyst) onto the surface of photocatalyst, both of which are conducive to the outstanding photocatalytic activity and stability. Accordingly, this work can provide guidance to design a stable and efficient photocatalyst by copolymerization for visible-light-driven H2 production.

[Identification of a novel ABO B(A)07 allele].

OBJECTIVE: To explore the molecular basis for a novel B(A) phenotype. METHODS: Genomic DNA was abstracted from peripheral blood sample from the proband. ABO genotyping were carried out with sequence specific primer PCR (PCR-SSP). Exons 6 and 7 of the ABO gene were amplified with PCR and sequenced. RESULTS: Anti-A serum could not be adsorbed or eluted by the donor's red blood cells, and no irregular antibodies were found in the plasma. PCR-SSP showed that the ABO genotype of the donor was ABO *B/O. Sequencing results showed that one of the alleles was ABO *O02, while the other could not be defined but contained the following mutation points, 297A>G, 526C>G, 657C>T, 701C>T, 703G>A, 796C>A, 803G>C, and 930G>A. The data was accepted by the GenBank (the loading code was KM974887) and the Blood Group Antigen Mutation Database, and was confirmed to be a novel allele of B(A). CONCLUSION: A novel allele ABO *B(A)07 with 701C>T has been identified, which may facilitate further study on blood antigen variants and typing of the blood groups.

[Immunoserology and RHD Genotype Analysis of DVI Type 3 Genotype Pregnant Women with Anti-D].

OBJECTIVE: To performe the immuneserological and RHD Genotype analyses for DVI type 3 genotype pregnemt women with anti-D. METHODS: RhD blood type of this pregnant women was identified by common serological methods, then the blood group specific antibodies was screened and identified; the polymerase chain reaction-sequence specific primer(PCR-SSP) was used to identify the pregnant women's RHD genotype; RhD blood group for the pregnant women, her spouse and daughter was genogrouped and genetically analyzed by multiplex ligation-dependent probe amplification(MLPA). The heredity of this family was analyzed finally. RESULTS: The titer of IgG anti-D in the pregnant woman serum was 1:8; the PCR-SSP showed that the 3rd to 6th exons of RHD gene were missing in the pregnant woman. the genotype of pregnant woman was identified as DVI type 3; the MLPA analysis showed that this pregnant women owned only one RHD allele with 3rd to 6th exons missed, and her genotype was identified as CDVIe/cde; her spouse was identified as CDe/CDe homozygous genotype, and her daughter as CDe/CDVIe. CONCLUSION: Accurate identification of RhD blood type is of great significance for a safe and effective clinical blood transfusion strategy, and for taking appropriate measures to prevent hemolytic disease of newborn (HDN) at women childbearing age.

Wnt5a Promotes Cortical Neuron Survival by Inhibiting Cell-Cycle Activation.

ß-Amyloid protein (Aß) is thought to cause neuronal loss in Alzheimer's disease (AD). Aß treatment promotes the re-activation of a mitotic cycle and induces rapid apoptotic death of neurons. However, the signaling pathways mediating cell-cycle activation during neuron apoptosis have not been determined. We find that Wnt5a acts as a mediator of cortical neuron survival, and Aß42 promotes cortical neuron apoptosis by downregulating the expression of Wnt5a. Cell-cycle activation is mediated by the reduced inhibitory effect of Wnt5a in Aß42 treated cortical neurons. Furthermore, Wnt5a signals through the non-canonical Wnt/Ca2+ pathway to suppress cyclin D1 expression and negatively regulate neuronal cell-cycle activation in a cell-autonomous manner. Together, aberrant downregulation of Wnt5a signaling is a crucial step during Aß42 induced cortical neuron apoptosis and might contribute to AD-related neurodegeneration.

Mussel-inspired one-pot synthesis of a fluorescent and water-soluble polydopamine-polyethyleneimine copolymer.

Inspired by the molecular mechanics of mussel adhesive formation, a novel water-soluble fluorescent macromolecule (polydopamine-polyethyleneimine (PDA-PEI)) is prepared by one-pot copolymerization of dopamine (DA) and PEI. In this method, DA is polymerized to form PDA, which is then coupled with PEI mainly through Michael addition. The fluorescence property of PDA-PEI is mainly attributed to the Michael addition of PEI on the 5,6-dihydroxyindole (DHI) units of PDA, where PEI can form hydrogen bonds with oxidative products such as DHI and force the DHI units to twist out of plane, resulting in a decrease in the intra- and intermolecular coupling of PDA. In addition, the influence of various metal cations on the fluorescence of the PDA-PEI copolymer is investigated. This work may facilitate the development of new strategies for controlling the emission characteristics of PDA.

An air-supported liquid crystal system for real-time reporting of host-guest inclusion events.

A new method for reporting host-guest inclusion phenomena using an air-supported liquid crystal (LC) system based on cyclodextrins (CDs) was developed. In this work inclusion complexation of ß-CD with sodium dodecyl sulfate (SDS) or with methylene blue (MB) using SDS as the probe was visualized using the LC, according to the principle that the orientation of LCs was coupled to the organization of SDS molecules.

[Short-course kidney-invigorating therapy improves near-term semen quality in asthenozoospermic men with kidney deficiency].

OBJECTIVE: To evaluate the effect of short-course kidney-invigorating therapy on near-term semen quality in asthenozoospermic men with kidney deficiency. METHODS: Based on the differential types in traditional Chinese medicine, 121 asthenozoospermia patients received at our clinic of andrology were divided into groups A (kidney-yin deficiency), B (kidney-yang deficiency) and C (spleen and kidney deficiency), and treated with Yougui Decoction plus Wuziyanzong Pills, Jinkuishenqi Pills plus Wuziyanzong Pills, and Shizi Decoction plus Liujunzi Decoction, respectively, all given once daily for 4 weeks. Sperm parameters of the patients were analyzed with the computer-assisted sperm analysis system before and after treatment and compared among the three groups. RESULTS: The baseline sperm concentrations in groups A, B and C ([70.4 +/- 38.6], [73.5 +/- 40.2] and [56.0 +/-34.4] x 10(6)/ml) showed no significant differences from those after medication ([74.4 +/- 32.6], [67.0 +/- 30.8] and [58.6 +/- 24.6] x 10(6)/ml) (P > 0.05). The percentages of grade a sperm in the three groups were (12.9 +/- 5.3)%, (13.7 +/- 7.7)% and (12.9 +/- 6.4)% respectively after treatment, significantly higher than (9.9 +/- 6.7)%, (9.3 +/- 5.4)% and (9.0 +/- 6.8)% before treatment (P < 0.05), and so were the percentages of grade a + b sperm ([37.4 +/- 10.2 ]%, [35.7 +/- 13.7]% and [35.9 +/- 12.3]% after treatment versus [29.6 +/- 13.2]%, [27.5 +/- 10.4]% and [28.3 +/- 12.1]% before treatment, P < 0.05). All the three groups showed significantly increased sperm motility after treatment ([53.8 +/- 10.5]%, [52.6 +/- 15.2]% and [51.1 +/- 13.1]%) as compared with the baseline levels ([44.3 +/- 14.0]%, [43.5 +/- 15.0]% and [42.4 +/- 14.9]%) (P < 0.05). The cure rate and total effectiveness rate were significantly higher in group B than in A (P < 0.05), but had no significant differences between either A and C or B and C (P > 0.05). CONCLUSION: Short-course kidney-invigorating therapy can significantly improve near-term semen quality in asthenozoospermic men with kidney asthenia, especially in those with kidney-yang deficiency, and it has no obvious adverse effects.

[Rosuvastatin improves myocardial function and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction and percutaneous coronary intervention].

OBJECTIVE: To evaluate the effect of rosuvastatin on the functions of the surviving myocardium and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction (STEMI) and percutaneous coronary intervention (PCI). METHODS: Sixty-five STEMI patients were randomized to receive 40 mg simvastatin (n=32) or 10 mg rosuvastatin (n=33) before sleep in addition to conventional medications. Before PCI and after the 12-month medications, the plasma levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), C-reactive protein (CRP) and tumor necrosis factor-α (TNF-α) were measured, and echocardiography and (99)Tc(m)-MIBI single-photon emission computed tomography (SPECT) were performed to assess the therapeutic effects. RESULTS: At the end of 12 months, the patients in simvastatin group showed significantly reduced total cholesterol, LDL-C, CRP, TNF-α, and (99)Tc(m)-MIBI uptake fraction. In rosuvastatin group, these reductions were even more obvious; the intima media thickness (IMT) of the common carotid artery was reduced significantly after a 12-month rosuvastatin therapy, but almost remained unchanged after simvastatin therapy. CONCLUSION: Rosuvastatin therapy in addition to conventional medications can significantly reduce IMT and improve the functions of the surviving myocardium in patients with STEMI after PCI.